Loading...

GoodRx Holdings, Inc. Peer Comparison

Metric Value Ranking
Market Cap $1.8 Billion 7/18 VEEV
$37.9B
DOCS
$14.1B
PRVA
$2.9B
CERT
$2.2B
TDOC
$2.2B
PGNY
$1.9B
GDRX
$1.8B
SDGR
$1.7B
NXGN
$1.6B
TXG
$1.4B
EVH
$1.1B
HSTM
$1.0B
TALK
$675.7M
DH
$605.3M
ACCD
$563.6M
NRC
$405.0M
HCAT
$331.0M
AMWL
$189.2M
Gross Margin 94% 3/18 PRVA
100%
HSTM
95%
GDRX
94%
DOCS
90%
DH
78%
VEEV
75%
TDOC
72%
TXG
70%
CERT
61%
NRC
53%
SDGR
50%
NXGN
46%
TALK
46%
HCAT
45%
ACCD
44%
AMWL
37%
PGNY
21%
EVH
13%
Profit Margin 6% 5/18 DOCS
32%
VEEV
27%
NRC
16%
HSTM
8%
GDRX
6%
PGNY
4%
NXGN
3%
PRVA
1%
CERT
-1%
TALK
-3%
EVH
-5%
TDOC
-5%
HCAT
-19%
TXG
-24%
AMWL
-71%
SDGR
-100%
ACCD
-100%
DH
-100%
EBITDA margin 7% 6/18 DOCS
39%
NRC
27%
VEEV
26%
HSTM
24%
NXGN
11%
GDRX
7%
PGNY
4%
PRVA
2%
TALK
0%
EVH
-1%
TDOC
-7%
CERT
-7%
HCAT
-9%
ACCD
-15%
TXG
-16%
AMWL
-51%
DH
-178%
SDGR
-194%
Quarterly Revenue $195.3 Million 6/18 VEEV
$699.2M
TDOC
$640.5M
EVH
$621.4M
PRVA
$437.9M
PGNY
$286.6M
GDRX
$195.3M
NXGN
$176.4M
TXG
$151.7M
TALK
$138.8M
DOCS
$136.8M
ACCD
$105.1M
CERT
$94.8M
HCAT
$76.4M
HSTM
$73.1M
DH
$62.7M
AMWL
$61.0M
NRC
$35.8M
SDGR
$35.3M
Quarterly Earnings $12.3 Million 3/18 VEEV
$185.8M
DOCS
$44.2M
GDRX
$12.3M
PGNY
$10.4M
HSTM
$5.7M
NRC
$5.7M
NXGN
$5.1M
PRVA
$3.5M
CERT
-$1.4M
TALK
-$3.6M
HCAT
-$14.7M
EVH
-$31.2M
TDOC
-$33.3M
TXG
-$35.8M
SDGR
-$38.1M
AMWL
-$43.5M
ACCD
-$121.3M
DH
-$130.9M
Quarterly Free Cash Flow $123.6 Million 3/18 TDOC
$168.8M
VEEV
$164.1M
GDRX
$123.6M
DOCS
$70.1M
PGNY
$42.7M
PRVA
$38.2M
HSTM
$33.6M
CERT
$25.5M
DH
$20.1M
TXG
$17.8M
EVH
$12.4M
HCAT
$12.2M
NRC
$7.8M
TALK
$4.6M
ACCD
-$7.8M
NXGN
-$19.0M
AMWL
-$24.4M
SDGR
-$34.6M
Trailing 4 Quarters Revenue $790.4 Million 6/18 VEEV
$2.7B
TDOC
$2.6B
EVH
$2.5B
PRVA
$1.7B
PGNY
$1.1B
GDRX
$790.4M
NXGN
$695.1M
TXG
$629.7M
DOCS
$516.8M
ACCD
$446.7M
CERT
$372.8M
HCAT
$302.1M
HSTM
$288.0M
TALK
$272.7M
DH
$255.8M
AMWL
$254.0M
SDGR
$193.3M
NRC
$144.2M
Trailing 4 Quarters Earnings -$7.9 Million 9/18 VEEV
$699.2M
TDOC
$640.5M
EVH
$621.4M
PRVA
$437.9M
PGNY
$286.6M
GDRX
$195.3M
NXGN
$176.4M
TXG
$151.7M
TALK
$138.8M
DOCS
$136.8M
ACCD
$105.1M
CERT
$94.8M
HCAT
$76.4M
HSTM
$73.1M
DH
$62.7M
AMWL
$61.0M
NRC
$35.8M
SDGR
$35.3M
Quarterly Earnings Growth 132% 1/18 GDRX
132%
CERT
97%
AMWL
68%
TXG
62%
HSTM
48%
DOCS
44%
TDOC
42%
SDGR
39%
VEEV
37%
HCAT
33%
DH
24%
TALK
19%
EVH
6%
NRC
-28%
PGNY
-34%
PRVA
-37%
NXGN
-63%
ACCD
-476%
Annual Earnings Growth -106% 15/18 TALK
63%
DOCS
50%
AMWL
48%
VEEV
42%
EVH
35%
TXG
35%
HCAT
34%
HSTM
21%
CERT
11%
PGNY
-6%
NRC
-9%
ACCD
-51%
PRVA
-53%
DH
-85%
GDRX
-106%
NXGN
-136%
SDGR
-261%
TDOC
-289%
Quarterly Revenue Growth 8% 6/18 TALK
259%
DOCS
20%
VEEV
13%
NXGN
11%
CERT
11%
GDRX
8%
ACCD
6%
PRVA
5%
HSTM
4%
HCAT
3%
PGNY
2%
EVH
0%
TXG
-1%
AMWL
-1%
TDOC
-3%
DH
-4%
NRC
-6%
SDGR
-17%
Annual Revenue Growth 6% 8/18 TALK
87%
EVH
75%
SDGR
31%
DOCS
18%
ACCD
15%
NXGN
12%
VEEV
11%
GDRX
6%
TXG
6%
HSTM
4%
CERT
4%
PRVA
4%
HCAT
3%
DH
3%
PGNY
2%
AMWL
2%
TDOC
-1%
NRC
-2%
Cash On Hand $423.8 Million 3/18 TDOC
$1.2B
VEEV
$1.0B
GDRX
$423.8M
PRVA
$422.0M
TXG
$398.2M
HCAT
$328.3M
AMWL
$244.6M
CERT
$233.0M
ACCD
$185.9M
DOCS
$184.2M
SDGR
$160.4M
DH
$137.6M
TALK
$119.0M
EVH
$96.6M
PGNY
$91.5M
HSTM
$57.5M
NXGN
$53.9M
NRC
$3.5M
Short Term Debt $9.3 Million 6/18 TDOC
$550.7M
HCAT
$233.8M
SDGR
$16.9M
ACCD
$14.7M
TXG
$9.4M
GDRX
$9.3M
VEEV
$9.2M
NRC
$8.7M
EVH
$6.2M
AMWL
$3.7M
NXGN
$3.5M
CERT
$3.0M
PRVA
$2.6M
DH
$2.5M
DOCS
$2.2M
PGNY
-$0
TALK
-$0
HSTM
-$27.6M
Long Term Debt $47.7 Million 9/18 TDOC
$1.6B
EVH
$629.0M
CERT
$303.5M
NXGN
$270.0M
HCAT
$130.6M
SDGR
$103.3M
TXG
$76.5M
VEEV
$62.5M
GDRX
$47.7M
NRC
$44.9M
ACCD
$21.1M
HSTM
$17.9M
PGNY
$16.6M
DOCS
$11.3M
DH
$8.3M
AMWL
$5.4M
PRVA
$3.6M
TALK
$0
PE -1.00 7/18 PRVA
225.89
DOCS
81.02
VEEV
56.89
HSTM
51.27
PGNY
32.74
NRC
14.96
GDRX
-1.00
EVH
-1.00
TDOC
-1.00
HCAT
-1.00
NXGN
-1.00
TXG
-1.00
SDGR
-1.00
ACCD
-1.00
AMWL
-1.00
CERT
-1.00
DH
-1.00
TALK
-1.00
PS 2.33 9/18 DOCS
27.29
VEEV
14.26
SDGR
8.98
CERT
5.90
HSTM
3.51
NRC
2.81
TALK
2.48
DH
2.37
GDRX
2.33
NXGN
2.31
TXG
2.27
PRVA
1.69
PGNY
1.65
ACCD
1.26
HCAT
1.10
TDOC
0.83
AMWL
0.74
EVH
0.45
PB 2.64 10/18 DOCS
14.68
NRC
11.70
VEEV
6.89
TALK
5.75
PRVA
4.37
PGNY
4.31
SDGR
3.86
NXGN
3.79
HSTM
2.84
GDRX
2.64
CERT
2.09
TXG
1.98
ACCD
1.80
TDOC
1.43
HCAT
0.93
EVH
0.91
DH
0.87
AMWL
0.54
PC 4.34 13/18 NRC
117.01
DOCS
76.56
VEEV
36.27
NXGN
29.82
PGNY
20.50
HSTM
17.58
EVH
11.59
SDGR
10.83
CERT
9.44
PRVA
6.86
TALK
5.68
DH
4.40
GDRX
4.34
TXG
3.59
ACCD
3.03
TDOC
1.74
HCAT
1.01
AMWL
0.77
Liabilities to Equity 0.95 7/18 NRC
2.81
TDOC
1.34
HCAT
1.29
EVH
1.23
ACCD
1.07
NXGN
1.03
GDRX
0.95
PRVA
0.79
DH
0.70
PGNY
0.52
SDGR
0.49
CERT
0.46
HSTM
0.41
AMWL
0.39
TXG
0.30
TALK
0.18
VEEV
0.17
DOCS
0.16
ROA -0.01 7/18 NRC
21%
DOCS
16%
VEEV
10%
PGNY
9%
HSTM
4%
PRVA
1%
GDRX
-1%
NXGN
-1%
CERT
-2%
EVH
-4%
TALK
-5%
HCAT
-10%
TXG
-19%
SDGR
-27%
TDOC
-28%
ACCD
-28%
DH
-31%
AMWL
-44%
ROE -0.01 7/18 NRC
78%
DOCS
18%
PGNY
13%
VEEV
12%
HSTM
6%
PRVA
2%
GDRX
-1%
NXGN
-1%
CERT
-3%
TALK
-6%
EVH
-9%
HCAT
-22%
TXG
-25%
SDGR
-40%
DH
-52%
ACCD
-58%
AMWL
-64%
TDOC
-65%
Current Ratio 2.06 12/18 DOCS
7.11
VEEV
6.78
TALK
6.70
TXG
4.36
AMWL
3.63
HSTM
3.41
CERT
3.15
SDGR
3.04
PGNY
2.93
DH
2.43
PRVA
2.37
GDRX
2.06
NXGN
1.97
EVH
1.96
ACCD
1.94
HCAT
1.78
TDOC
1.75
NRC
1.36
Quick Ratio 0.64 11/18 PRVA
225.89
DOCS
81.02
VEEV
56.89
HSTM
51.27
PGNY
32.74
NRC
14.96
GDRX
-1.00
EVH
-1.00
TDOC
-1.00
HCAT
-1.00
NXGN
-1.00
TXG
-1.00
SDGR
-1.00
ACCD
-1.00
AMWL
-1.00
CERT
-1.00
DH
-1.00
TALK
-1.00
Long Term Debt to Equity 0.07 9/18 NRC}
1.30
TDOC}
1.05
NXGN}
0.64
EVH}
0.61
HCAT}
0.37
CERT}
0.29
SDGR}
0.23
TXG}
0.11
GDRX}
0.07
ACCD}
0.07
HSTM}
0.05
PGNY}
0.04
AMWL}
0.02
VEEV}
0.01
PRVA}
0.01
DOCS}
0.01
DH}
0.01
TALK}
0.00
Debt to Equity 0.08 10/18 NRC
1.55
TDOC
1.05
HCAT
1.03
NXGN
0.65
EVH
0.61
CERT
0.29
SDGR
0.27
TXG
0.12
ACCD
0.09
GDRX
0.08
HSTM
0.05
PGNY
0.04
AMWL
0.03
DH
0.02
VEEV
0.01
PRVA
0.01
DOCS
0.01
TALK
0.00
Burn Rate -52.78 17/18 TALK
33.10
CERT
16.34
TXG
9.67
NXGN
8.14
AMWL
5.49
TDOC
5.31
HCAT
4.19
SDGR
3.45
EVH
1.67
ACCD
1.48
DH
1.04
NRC
-2.02
DOCS
-4.27
HSTM
-4.83
VEEV
-5.77
PGNY
-9.38
GDRX
-52.78
PRVA
-153.67
Cash to Cap 0.23 6/18 AMWL
1.29
HCAT
0.99
TDOC
0.58
ACCD
0.33
TXG
0.28
GDRX
0.23
DH
0.23
TALK
0.18
PRVA
0.15
CERT
0.11
EVH
0.09
SDGR
0.09
HSTM
0.06
PGNY
0.05
VEEV
0.03
NXGN
0.03
NRC
0.01
DOCS
0.01
CCR 10.08 2/18 PRVA
10.79
GDRX
10.08
HSTM
5.87
PGNY
4.10
DOCS
1.59
NRC
1.38
SDGR
0.91
VEEV
0.88
AMWL
0.56
ACCD
0.06
DH
-0.15
EVH
-0.40
TXG
-0.50
HCAT
-0.83
TALK
-1.28
NXGN
-3.76
TDOC
-5.07
CERT
-18.58
EV to EBITDA 110.90 6/18 TALK}
5623.21
PRVA}
265.89
DOCS}
262.24
VEEV}
203.53
PGNY}
144.50
GDRX}
110.90
NXGN}
93.63
HSTM}
55.32
NRC}
47.67
AMWL}
1.49
DH}
-4.29
SDGR}
-24.80
ACCD}
-25.69
TXG}
-47.23
HCAT}
-54.52
TDOC}
-56.19
EVH}
-203.17
CERT}
-354.59
EV to Revenue 1.87 9/18 DOCS
26.96
VEEV
13.89
SDGR
8.78
CERT
6.10
HSTM
3.37
NRC
3.16
NXGN
2.63
TALK
2.04
GDRX
1.87
DH
1.87
TXG
1.78
PGNY
1.58
PRVA
1.45
HCAT
1.22
TDOC
0.96
ACCD
0.91
EVH
0.67
AMWL
-0.18